UNC-Pharmaceutical Collaboration to Cure HIV

The University of North Carolina at Chapel Hill and the pharmaceutical company GSK (GlaxoSmithKline) are today announcing an unusually close collaboration in an effort to find a cure for HIV. The company will provide $4 million a year for five years to support a new research center focused on developing a cure for HIV. In addition, the company will locate some researchers at Chapel Hill for the project. UNC and the company will also create a new company, Qura Therapeutics, that will manage intellectual property and commercialization of any discoveries from the collaboration.